Contributor contact details |
|
ix | |
Woodhead Publishing Series in Biomaterials |
|
xiii | |
|
1 Microscopy techniques for analyzing the phase nature and morphology of biomaterials |
|
|
1 | (33) |
|
|
1.1 Introduction: basic imaging concepts |
|
|
1 | (2) |
|
1.2 Image perception and interpretation |
|
|
3 | (2) |
|
|
5 | (15) |
|
1.4 Laser scanning confocal microscopy (LSCM) |
|
|
20 | (2) |
|
1.5 Scanning electron microscopy (SEM) |
|
|
22 | (6) |
|
1.6 Atomic force microscopy (AFM) |
|
|
28 | (5) |
|
|
33 | (1) |
|
2 Scattering techniques for structural analysis of biomaterials |
|
|
34 | (38) |
|
|
|
34 | (2) |
|
|
36 | (5) |
|
2.3 Wide-angle X-ray diffraction |
|
|
41 | (8) |
|
2.4 Measuring orientation using X-ray diffraction |
|
|
49 | (7) |
|
2.5 Small-angle scattering techniques |
|
|
56 | (1) |
|
2.6 Small-angle X-ray scattering (SAXS) |
|
|
57 | (4) |
|
2.7 Small-angle neutron scattering (SANS) |
|
|
61 | (6) |
|
|
67 | (1) |
|
|
68 | (4) |
|
3 Quantitative assays for measuring cell adhesion and motility in biomaterials |
|
|
72 | (29) |
|
|
|
72 | (8) |
|
3.2 Cell attachment assays |
|
|
80 | (1) |
|
3.3 Cell adhesion strength |
|
|
81 | (3) |
|
3.4 Collective motility of cell populations |
|
|
84 | (3) |
|
3.5 Individual cell motility |
|
|
87 | (3) |
|
3.6 Conclusion and future trends |
|
|
90 | (2) |
|
|
92 | (9) |
|
4 Assays for determining cell differentiation in biomaterials |
|
|
101 | (37) |
|
|
|
|
101 | (1) |
|
4.2 Deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) assays |
|
|
102 | (11) |
|
4.3 Protein and chemical assays |
|
|
113 | (6) |
|
|
119 | (9) |
|
|
128 | (2) |
|
|
130 | (8) |
|
5 Bioreactors for evaluating cell infiltration and tissue formation in biomaterials |
|
|
138 | (44) |
|
|
|
|
|
138 | (1) |
|
|
139 | (2) |
|
5.3 Evaluation of cell infiltration and cell seeding |
|
|
141 | (1) |
|
5.4 Evaluation of tissue formation |
|
|
142 | (18) |
|
5.5 Importance of computational fluid mechanics in modeling, imaging, and simulation of the bioreactors |
|
|
160 | (4) |
|
5.6 Failure of bioreactors |
|
|
164 | (2) |
|
|
166 | (1) |
|
|
166 | (1) |
|
5.9 Sources of further information and advice |
|
|
167 | (1) |
|
|
167 | (15) |
|
6 Studying molecular-scale protein--surface interactions in biomaterials |
|
|
182 | (42) |
|
|
6.1 Introduction: surface-induced thrombosis on artificial surfaces |
|
|
182 | (1) |
|
6.2 Process and changes during protein adsorption |
|
|
183 | (1) |
|
6.3 Factors affecting protein adsorption |
|
|
184 | (3) |
|
6.4 Models of protein adsorption and adsorption isotherms |
|
|
187 | (1) |
|
6.5 Protein adsorption kinetics |
|
|
187 | (1) |
|
|
188 | (1) |
|
6.7 Structure and functions of fibrinogen |
|
|
188 | (5) |
|
6.8 Intermolecular forces and interactions |
|
|
193 | (4) |
|
6.9 Adsorption profile and interfacial kinetics |
|
|
197 | (2) |
|
6.10 Competitive adsorption |
|
|
199 | (1) |
|
6.11 Atomic force microscopy (AFM) |
|
|
199 | (4) |
|
6.12 Interfacial properties of fibrinogen studied by AFM |
|
|
203 | (5) |
|
|
208 | (1) |
|
|
209 | (1) |
|
|
210 | (14) |
|
7 Assessing the mutagenic effects of biomaterials: analyzing the cellular genome and abnormalities |
|
|
224 | (38) |
|
|
|
|
224 | (1) |
|
|
225 | (2) |
|
|
227 | (6) |
|
7.4 Cytogenetic mutations |
|
|
233 | (10) |
|
7.5 Types of mutations that can occur at the chromosomal level |
|
|
243 | (6) |
|
7.6 Methods of detection of cytogenetic mutations |
|
|
249 | (3) |
|
7.7 Analyzing genomic organization and variations in genomic copy number |
|
|
252 | (1) |
|
7.8 Copy number variations (CNVs) |
|
|
253 | (2) |
|
7.9 Epigenetic effects on the genome |
|
|
255 | (3) |
|
7.10 Effects of biomaterials on mutagenesis |
|
|
258 | (2) |
|
|
260 | (1) |
|
7.12 Sources of further information and advice |
|
|
260 | (2) |
|
8 Using microarrays to measure cellular changes induced by biomaterials |
|
|
262 | (23) |
|
|
|
262 | (1) |
|
|
263 | (3) |
|
|
266 | (4) |
|
|
270 | (10) |
|
|
280 | (1) |
|
|
280 | (5) |
|
9 Standards and methods for assessing the safety and biocompatibility of biomaterials |
|
|
285 | (22) |
|
|
|
285 | (1) |
|
9.2 Regulatory definition of medical devices |
|
|
286 | (1) |
|
9.3 International Standards Organization (ISO) regulation and guidance |
|
|
286 | (2) |
|
9.4 United States Food and Drug Administration (FDA) regulation and guidance |
|
|
288 | (7) |
|
9.5 Regulation and guidance in Japan and other countries |
|
|
295 | (1) |
|
|
295 | (7) |
|
9.7 Phasing (timing) of non-clinical testing of medical devices |
|
|
302 | (1) |
|
9.8 Sources of further information and advice |
|
|
302 | (4) |
|
|
306 | (1) |
Index |
|
307 | |